Canadian Journal of Diabetes · 2019 · 19 citations · 15 references
BusinessDecision SciencesPharmacoeconomicsCost-utility AnalysisDecision AnalysisDecision TheoryConsumer ChoiceDiabetes MellitusDiscrete Choice ModelsDiscrete Choice TheoryPatient PreferencesUtility Elicitation MethodsDiabetes Medication UseDiscrete Choice Experiment DesignDiscrete Choice ModellingEliciting Patient PreferencesMedication Preference AssessmentPreference Utility EstimationPreference-based Utility MeasurementTreatment Choice Preferences
15
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey et al. · New England Journal of Medicine · 2017 · 7.8K citations · Full text
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text